AAAAAA

   
Results: 1-25 | 26-32
Results: 1-25/32
GUIDELINES FOR THE MANAGEMENT OF CANCER IN THE ELDERLY - INTRODUCTION
Authors: MONFARDINI S REPETTO L ZAGONEL V AUDISIO RA AAPRO M
Citation: S. Monfardini et al., GUIDELINES FOR THE MANAGEMENT OF CANCER IN THE ELDERLY - INTRODUCTION, Critical reviews in oncology/hematology, 27(2), 1998, pp. 85-85
SCREENING AND CHEMOPREVENTION
Authors: REPETTO L GRANETTO C VENTURINO A AAPRO M
Citation: L. Repetto et al., SCREENING AND CHEMOPREVENTION, Critical reviews in oncology/hematology, 27(2), 1998, pp. 111-115
BREAST-CANCER
Authors: AAPRO M PICCART M
Citation: M. Aapro et M. Piccart, BREAST-CANCER, Critical reviews in oncology/hematology, 27(2), 1998, pp. 135-137
GYNECOLOGICAL CANCERS
Authors: REPETTO L GRANETTO C AAPRO M PECORELLI S
Citation: L. Repetto et al., GYNECOLOGICAL CANCERS, Critical reviews in oncology/hematology, 27(2), 1998, pp. 147-150
OPTIMAL SELECTION OF ANTIEMETICS IN CHILDREN RECEIVING CANCER-CHEMOTHERAPY
Authors: ROILA F AAPRO M STEWART A
Citation: F. Roila et al., OPTIMAL SELECTION OF ANTIEMETICS IN CHILDREN RECEIVING CANCER-CHEMOTHERAPY, Supportive care in cancer, 6(3), 1998, pp. 215-220
CONTROL OF DELAYED NAUSEA AND VOMITING WITH GRANISETRON PLUS DEXAMETHASONE OR DEXAMETHASONE ALONE IN PATIENTS RECEIVING HIGHLY EMETOGENIC CHEMOTHERAPY - A DOUBLE-BLIND, PLACEBO-CONTROLLED, COMPARATIVE-STUDY
Authors: GOEDHALS L HERON JF KLEISBAUER JP PAGANI O SESSA C GIGER K CAVALLI F LUDWIG C AAPRO M BLEIBERG H DEWASH G DICATO M TAGNON A VANSTRAELEN D VINDEVOGHEL A ABRATT R FALKSON G BARLEY V CARMICHAEL J COLEMAN R DAVIDSON N GRIEVE R HARPER P ROBERTS J RUSTIN G NAMAN H SCHNEIDER M NOBLE A NETTER P CUPISSOL D BALMES P CALS L KHAYAT D CATIMEL G DUTIN JP BOUFETTE P ADENIS L MISSET J COLLERY P NOUVET G CHAVAILLON JM BLANCHON F POIRIER R ARNAUD A LECAER H CARLES P MUIR J BONNAUD F MARQUESTE L CLAVIER J GUERIN J TAYTARD A KEIZER H NORTIER J SLEE P WILS J RODENBURG C BURGHOUTS J DEWIT R GARCIAGIRON C JIMENEZLACAVE A CRUZHERNANDEZ J MASSUTISUREDA B HANS K FUCHS R KRIEGMAIR M SCHULLER J LAHOUSEN M PANNUTI F MONFARDINI S NILSSON S
Citation: L. Goedhals et al., CONTROL OF DELAYED NAUSEA AND VOMITING WITH GRANISETRON PLUS DEXAMETHASONE OR DEXAMETHASONE ALONE IN PATIENTS RECEIVING HIGHLY EMETOGENIC CHEMOTHERAPY - A DOUBLE-BLIND, PLACEBO-CONTROLLED, COMPARATIVE-STUDY, Annals of oncology, 9(6), 1998, pp. 661-666
QUESTIONS IN BREAST-CANCER - ANSWERS SINCE 1996
Authors: AAPRO M
Citation: M. Aapro, QUESTIONS IN BREAST-CANCER - ANSWERS SINCE 1996, Annals of oncology, 9, 1998, pp. 1-1
LONG-TERM, TOTALLY IMPLANTABLE CENTRAL VENOUS ACCESS PORTS CONNECTED TO A GROSHONG CATHETER FOR CHEMOTHERAPY OF SOLID TUMORS - EXPERIENCE FROM 178 CASES USING A SINGLE TYPE OF DEVICE
Authors: BIFFI R CORRADO F DEBRAUD F DELUCIA F SCARPA D TESTORI A ORSI F BELLOMI M MAURI S AAPRO M ANDREONI B
Citation: R. Biffi et al., LONG-TERM, TOTALLY IMPLANTABLE CENTRAL VENOUS ACCESS PORTS CONNECTED TO A GROSHONG CATHETER FOR CHEMOTHERAPY OF SOLID TUMORS - EXPERIENCE FROM 178 CASES USING A SINGLE TYPE OF DEVICE, European journal of cancer, 33(8), 1997, pp. 1190-1194
DOSE-FINDING STUDY OF HIGH-DOSE EPIRUBICIN (E) AND DOCETAXEL (T) AS FIRST LINE CHEMOTHERAPY IN ADVANCED BREAST-CANCER (ABC)
Authors: PAGANI O AAPRO M MARTINELLI G BAUER J BORNER M CRIVELLARI D THURLIMANN B VANDENBULCKE T GOLDHIRSCH A
Citation: O. Pagani et al., DOSE-FINDING STUDY OF HIGH-DOSE EPIRUBICIN (E) AND DOCETAXEL (T) AS FIRST LINE CHEMOTHERAPY IN ADVANCED BREAST-CANCER (ABC), European journal of cancer, 33, 1997, pp. 654-654
INTERIM-REPORT OF A PHASE-I STUDY OF DOCETAXEL (TAXOTERE(R)) IN COMBINATION WITH VINORELBINE IN CHEMOTHERAPY NAIVE PATIENTS WITH METASTATICOR INOPERABLE NON-SMALL-CELL LUNG-CANCER (NSCLC)
Authors: LECHEVALIER T MONNIER A AAPRO M DOUILLARD JY NAHON S SUN XS DEPAS T LORET C BOUGON N BERILLE J
Citation: T. Lechevalier et al., INTERIM-REPORT OF A PHASE-I STUDY OF DOCETAXEL (TAXOTERE(R)) IN COMBINATION WITH VINORELBINE IN CHEMOTHERAPY NAIVE PATIENTS WITH METASTATICOR INOPERABLE NON-SMALL-CELL LUNG-CANCER (NSCLC), European journal of cancer, 33, 1997, pp. 1053-1053
PHASE-II TRIALS OF DOCETAXEL (TAXOTERE(R)) IN ADVANCED OVARIAN-CANCER- AN UPDATED OVERVIEW
Authors: KAYE SB PICCART M AAPRO M FRANCIS P KAVANAGH J
Citation: Sb. Kaye et al., PHASE-II TRIALS OF DOCETAXEL (TAXOTERE(R)) IN ADVANCED OVARIAN-CANCER- AN UPDATED OVERVIEW, European journal of cancer, 33(13), 1997, pp. 2167-2170
A DOUBLE-BLIND CROSSOVER STUDY COMPARING PROPHYLACTIC INTRAVENOUS GRANISETRON ALONE OR IN COMBINATION WITH DEXAMETHASONE AS ANTIEMETIC TREATMENT IN CONTROLLING NAUSEA AND VOMITING ASSOCIATED WITH CHEMOTHERAPY
Authors: KIRCHNER V AAPRO M TERREY JP ALBERTO P
Citation: V. Kirchner et al., A DOUBLE-BLIND CROSSOVER STUDY COMPARING PROPHYLACTIC INTRAVENOUS GRANISETRON ALONE OR IN COMBINATION WITH DEXAMETHASONE AS ANTIEMETIC TREATMENT IN CONTROLLING NAUSEA AND VOMITING ASSOCIATED WITH CHEMOTHERAPY, European journal of cancer, 33(10), 1997, pp. 1605-1610
PHASE I-II STUDY OF VINORELBINE IN COMBINATION WITH 5-FLUOROURACIL AND FOLINIC ACID AS FIRST-LINE CHEMOTHERAPY IN METASTATIC BREAST-CANCER - A REGIMEN WITH A LOW SUBJECTIVE TOXIC BURDEN
Authors: NOLE F DEBRAUD F AAPRO M MINCHELLA I DEPAS M ZAMPINO MG MONTI S ANDREONI G GOLDHIRSCH A
Citation: F. Nole et al., PHASE I-II STUDY OF VINORELBINE IN COMBINATION WITH 5-FLUOROURACIL AND FOLINIC ACID AS FIRST-LINE CHEMOTHERAPY IN METASTATIC BREAST-CANCER - A REGIMEN WITH A LOW SUBJECTIVE TOXIC BURDEN, Annals of oncology, 8(9), 1997, pp. 865-870
ELECTIVE SURGERY FOR GASTROINTESTINAL TUMORS IN THE ELDERLY
Authors: AUDISIO RA VERONESI P FERRARIO L CIPOLLA C ANDREONI B AAPRO M
Citation: Ra. Audisio et al., ELECTIVE SURGERY FOR GASTROINTESTINAL TUMORS IN THE ELDERLY, Annals of oncology, 8(4), 1997, pp. 317-326
EFFECTIVENESS OF ADJUVANT CHEMOTHERAPY IN COMBINATION WITH TAMOXIFEN FOR NODE-POSITIVE POSTMENOPAUSAL BREAST-CANCER PATIENTS
Authors: CASTIGLIONEGERTSCH M GOLDHIRSCH A GUSTERSON B BETTELHEIM R REED R GUSSET H GEISER K HURNY C BERNHARD J HANGARTNER A MAIBACH R PEDOWSKI R GELBER R PRICE K PETERSON H ZELEN M ISLEY M HINKLE R KAY RG HOLDAWAY IM HARVEY VJ JAGUSCH MF NEAVE L MASON BM EVANS B BENJAMIN CS CARTER JF GILLMAN JC MACK D BENSONCOOPER D MONFARDINI S GALLIGIONI E CRIVELLARI D BUONADONNA A MASSARUT S ROSSI C CANDIANI E CARBONE A VOLPE R TROVO MG RONCADIN M SANTINI GF VILLALTA D CORAN F MORASSUT S MARINI G SIMONCINI E MARPICATI P ZANIBONI A SARTORI U BARNI A CERUTTI L ALGHISI A RAFFAGLIO E GARATTINI MP ALBERTINI A GRIGOLATO F MORASSI L BERGONZINI R LAURIOLA C GUDGEON A DENT DM TILTMAN A HACKING A DOWDLE E STEYNOR P TOOP J SCHNURCH HG MOSNY D BENDER HG BOJAR H VERONESI A FOLADORE S PAMICH G BIANCHI G TORRETTA A RUDENSTAM CM WALLGREN A PERSSON S MATTSSON J CAHLIN E HAFSTROM LO HOLMBERG S HULTBORN R COLLDAHLJADERSTROM G GUSTAVSSON B CARLSSON G IVARSSON L THOREN O RUUSVIK O NICKLASSON LG DAHLIN S KARLSSON G LINDBERG B SUNDBACK A BERGEGARDH S SALANDER H ANDERSSON C HESSMAN Y NELZEN O HEIDEMAN M RAMHULT T SVENSSON JH LIDBERG P BJORK S LINDTNER J ERZEN D CERAR O STABUC B GOLOUH R LAMOVEC J SEBEK S KRAMBERGER M VRHOVEC I CORTESFUNES H MARTINEZTELLO F MENDIOLA C CRUZVIGO F LARRODERA ML SIERRA A MIRANDA P ALONSO S COLLINS J SNYDER R GREGORY P BURAS WI GREEN M GALE T HENDERSON M HART S NEIL S KITCHEN P LOVELL R MCLENNAN R REED R RUSSELL I SCHWARZ M BASSER R ROBERTSON A GILL P CARTER ML MALYCHA P YEOH E WARD G LEONG ASY LOMMAXSMITH J HOOSFALL D DANGELO R BYRNE M VANHAZEL G DEWAR J BUCK M SHEINER HJ INGRAM D STERRETT G HAHNEL R FORBES JF STEWARD J DARBAR SW BISHOP JM SIMMS B ZIOGAS V TATTERSALL MHN COATES A NIESCHE F WEST R RENWICK S DONOVAN J DUVAL P SIMES RJ NG A GLENN D NORTH RA BEITH J OCONNOR RG RICE M STEVENS G FEY M BARTH A DREHER E ISENSCHMID M SCHNEIDER H BUSER K LUDIN J LUTHI JM ALTERMATT HJ LAISSUE JA MARKWALDER R BURGI H SENN HJ THURLIMANN B JUNGI WF MORANT R OEHLSCHLEGEL C HARDMEIER T LUSCHER K RIES G TOPFER M LORENZ U BENZ D SCHILTKNECHT O SPATI B SCHMID L CAVALLI F SESSA C BRONZ L MARTINELLI G MULLER W LUSCIETI P PASSEGA E PEDRINIS E REY P MARTINOLI S SPINELLI A GALFETTI MA LOMBARDI A PEDRAZZINI A LOSA G VARINI M GINIER M HERRMANN R HARDER JF LAFFER U ALMENDRAL AC EPPENBERGER U TORHORST J SIEGENTHALER P PIGUET D BARRELET V BAUMANN RP JOSS R SAUTER C METZGER U ENGELER V HALLER U KOCHLI O LEYVRAZ S PEREY L ANANI P GOMEZ F MIRIMANOFF RO CHAPUIS G DEGRANDI P REYMOND P ALBERTO P SCHAFER P KRAUER F FORNI M AAPRO M EGELI R MEGEVAND R JACOTDESCOMBES E SCHINDLER A NOSEDA G WEBER W LEHMANN W
Citation: M. Castiglionegertsch et al., EFFECTIVENESS OF ADJUVANT CHEMOTHERAPY IN COMBINATION WITH TAMOXIFEN FOR NODE-POSITIVE POSTMENOPAUSAL BREAST-CANCER PATIENTS, Journal of clinical oncology, 15(4), 1997, pp. 1385-1394
THE SCIENTIFIC RATIONALE FOR DEVELOPING TAXOIDS
Authors: AAPRO M
Citation: M. Aapro, THE SCIENTIFIC RATIONALE FOR DEVELOPING TAXOIDS, Anti-cancer drugs, 7, 1996, pp. 33-36
AN EORTC RANDOMIZED TRIAL OF DOXORUBICIN+ -CISPLATIN IN ADVANCED OR RECURRENT ENDOMETRIAL CARCINOMA/
Authors: AAPRO M SAHMOUD T TEODOROVIC I BOLIS G CHEVALLIER B VANDERBURG M POVEDA A DEOLIVEIRA C PECORELLI S
Citation: M. Aapro et al., AN EORTC RANDOMIZED TRIAL OF DOXORUBICIN+ -CISPLATIN IN ADVANCED OR RECURRENT ENDOMETRIAL CARCINOMA/, Journal of clinical oncology, 14(5), 1996, pp. 2014-2014
ADJUVANT CYCLOPHOSPHAMIDE, METHOTREXATE, AND FLUOROURACIL VERSUS FLUOROURACIL, EPIRUBICIN, AND CYCLOPHOSPHAMIDE CHEMOTHERAPY IN PREMENOPAUSAL WOMEN WITH AXILLARY NODE-POSITIVE OPERABLE BREAST-CANCER - RESULTS OF A RANDOMIZED TRIAL
Authors: COOMBES RC BLISS JM WILS J MORVAN F ESPIE M AMADORI D GAMBROSIER P RICHARDS M AAPRO M VILLARGRIMALT A MCARDLE C PEREZLOPEZ FR VASSILOPOULOS P FERREIRA EP CHILVERS CED COOMBES G WOODS EM MARTY M
Citation: Rc. Coombes et al., ADJUVANT CYCLOPHOSPHAMIDE, METHOTREXATE, AND FLUOROURACIL VERSUS FLUOROURACIL, EPIRUBICIN, AND CYCLOPHOSPHAMIDE CHEMOTHERAPY IN PREMENOPAUSAL WOMEN WITH AXILLARY NODE-POSITIVE OPERABLE BREAST-CANCER - RESULTS OF A RANDOMIZED TRIAL, Journal of clinical oncology, 14(1), 1996, pp. 35-45
CYTOTOXIC AGENTS WITH ACTIVITY IN BREAST-CANCER PATIENTS PREVIOUSLY EXPOSED TO ANTHRACYCLINES - CURRENT STATUS AND FUTURE-PROSPECTS
Authors: PICCART MJ RAYMOND E AAPRO M EISENHAUER EA CVITKOVIC E
Citation: Mj. Piccart et al., CYTOTOXIC AGENTS WITH ACTIVITY IN BREAST-CANCER PATIENTS PREVIOUSLY EXPOSED TO ANTHRACYCLINES - CURRENT STATUS AND FUTURE-PROSPECTS, European journal of cancer, 31A, 1995, pp. 1-10
DEVELOPMENT OF AN ACTIVE CHOP-MODIFIED REGIMEN WHICH ALLOWS MORE CONTINUOUS AND BETTER TOLERATED TREATMENT FOR DIFFUSE AGGRESSIVE NON-HODGKINS-LYMPHOMAS (NHL)
Authors: MARTINELLI G ZUCCA E AAPRO M CAVALLI F
Citation: G. Martinelli et al., DEVELOPMENT OF AN ACTIVE CHOP-MODIFIED REGIMEN WHICH ALLOWS MORE CONTINUOUS AND BETTER TOLERATED TREATMENT FOR DIFFUSE AGGRESSIVE NON-HODGKINS-LYMPHOMAS (NHL), European journal of cancer, 31A, 1995, pp. 816-816
PATIENT PREFERENCE OF ANTIEMETIC TREATMENT - A PLACEBO-CONTROLLED, DOUBLE-BLIND COMPARISON OF GRANISETRON WITH GRANISETRON PLUS DEXAMETHASONE
Authors: TERREY JP AAPRO M KIRCHNER V ALBERTO P
Citation: Jp. Terrey et al., PATIENT PREFERENCE OF ANTIEMETIC TREATMENT - A PLACEBO-CONTROLLED, DOUBLE-BLIND COMPARISON OF GRANISETRON WITH GRANISETRON PLUS DEXAMETHASONE, European journal of cancer, 31A, 1995, pp. 895-895
EARLY CLINICAL-STUDIES WITH DOCETAXEL
Authors: AAPRO M BRUNO R
Citation: M. Aapro et R. Bruno, EARLY CLINICAL-STUDIES WITH DOCETAXEL, European journal of cancer, 31A, 1995, pp. 7-10
DOCETAXEL IN ADVANCED OVARIAN-CANCER - PRELIMINARY-RESULTS FROM 3 PHASE-II TRIALS
Authors: KAYE SB PICCART M AAPRO M KAVANAGH J
Citation: Sb. Kaye et al., DOCETAXEL IN ADVANCED OVARIAN-CANCER - PRELIMINARY-RESULTS FROM 3 PHASE-II TRIALS, European journal of cancer, 31A, 1995, pp. 14-17
POPULATION PHARMACOKINETICS OF DOCETAXEL DURING PHASE-I STUDIES USINGNONLINEAR MIXED EFFECT MODELING AND NONPARAMETRIC MAXIMUM-LIKELIHOOD-ESTIMATION
Authors: LAUNAYILIADIS MC BRUNO R COSSON V VERGNIOL JC OULIDAISSA D MARTY M CLAVEL M AAPRO M LEBAIL N ILIADIS A
Citation: Mc. Launayiliadis et al., POPULATION PHARMACOKINETICS OF DOCETAXEL DURING PHASE-I STUDIES USINGNONLINEAR MIXED EFFECT MODELING AND NONPARAMETRIC MAXIMUM-LIKELIHOOD-ESTIMATION, Cancer chemotherapy and pharmacology, 37(1-2), 1995, pp. 47-54
CLINICAL EFFICACY OF CANCER SUBCUTANEOUS IMMUNOTHERAPY WITH INTERLEUKIN-2 IN RELATION TO THE PRETREATMENT LEVELS OF TUMOR-GROWTH FACTOR INSULIN-LIKE GROWTH-FACTOR-I
Authors: LISSONI P BARNI S ARDIZZOIA A FRIGERIO F PAOLOROSSI F CAZZANIGA M TANCINI G ROCCO F AAPRO M
Citation: P. Lissoni et al., CLINICAL EFFICACY OF CANCER SUBCUTANEOUS IMMUNOTHERAPY WITH INTERLEUKIN-2 IN RELATION TO THE PRETREATMENT LEVELS OF TUMOR-GROWTH FACTOR INSULIN-LIKE GROWTH-FACTOR-I, Tumori, 81(4), 1995, pp. 261-264
Risultati: 1-25 | 26-32